Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | COO and General Counsel | $408K | +$21.3K | +5.5% | May 31, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|